SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 5, 2003
INVERNESS MEDICAL INNOVATIONS, INC.
(Exact name of registrant as specified in charter)
|
Delaware |
|
001-16789 |
|
04-3565120 |
|
(State or Other
Jurisdiction |
|
(Commission File Number) |
|
(IRS Employer |
|
|
|
|
|
|
|
51 Sawyer Road, Suite 200, Waltham, Massachusetts 02453 |
||||
|
(Address of Principal Executive Offices) (Zip Code) |
||||
|
|
||||
|
(781) 647-3900 |
||||
|
(Registrant’s telephone number, including area code) |
||||
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits.
|
Exhibit No. |
|
Description |
|
|
|
|
|
99.1 |
|
Press Release dated November 5, 2003, titled “Inverness Medical Innovations Announces Third Quarter Results” |
Item 12. Results of Operations and Financial Condition.
On November 5, 2003, Inverness Medical Innovations, Inc. issued a press release titled “Inverness Medical Innovations Announces Third Quarter Results,” a copy of which is furnished with this Current Report on Form 8-K as Exhibit 99.1.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
INVERNESS MEDICAL INNOVATIONS, INC. |
||
|
|
|
||
|
|
|
||
|
Date: November 5, 2003 |
By: |
/s/ Christopher Lindop |
|
|
|
|
Christopher Lindop |
|
|
|
|
Chief Financial Officer |
|
3
EXHIBIT INDEX
|
Exhibit No. |
|
Description |
|
|
|
|
|
99.1 |
|
Press Release dated November 5, 2003, titled “Inverness Medical Innovations Announces Third Quarter Results” |
4